agile lifescience technologies india private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 14 September 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 21 bids — MARK ENTERPRISES appeared in 6 of them.
AGILE LIFESCIENCE TECHNOLOGIES INDIA PRIVATE LIMITED
AGILE LIFESCIENCE TECHNOLOGIES INDIA PRIVATE LIMITED
Financial Details
Registered Office
Plot No. A-255, 1st Floor TTC Industrial Area, MahapeNA-Navi Mumbai-Maharashtra-400701-India
Industry Classification
Manufacturing (Machinery & Equipments)
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TendersAi transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
68
Contract Value
₹12.01 Cr
L1 Bids
13
Recent Win Rate
25.0%
Performance Analytics
Agile Lifescience Technologies India: Government Tender Performance Analysis
Agile Lifescience Technologies India Private Limited, a key player in the Indian medical equipment manufacturing sector, has actively participated in 67 government tenders. This comprehensive analysis, powered by TenderAI, examines their tender performance, win patterns, and competitive standing in the Indian government procurement landscape from April 2018 to March 2025. The analysis focuses on Agile Lifescience Technologies India tenders and aims to provide insights into how the company can improve its performance in the Indian market.
Executive Summary
Agile Lifescience Technologies India's tender journey includes 67 bids, with a 17.9% win rate securing 12 L1 positions between April 2018 and March 2025. Although demonstrating a strong initial competitive pricing strategy, their qualification rate of 49.3% signals room for improvement in technical compliance. The company's bid strategy also needs optimization to increase the number of wins. Their financial health score stands at 41.3, rated as 'Concerning', primarily due to low contract value and growth components, based on TenderAI's proprietary scoring system. Agile Lifescience Technologies India needs to focus on winning more tenders to improve its growth and financial position.
Their market position is challenged by competitors with better win rates, and they need to develop strategies to overcome this. Agile Lifescience Technologies India has shown notable engagement with the Department of Atomic Energy, securing significant contracts, indicating specialized expertise. While they also bid to Department Of Higher Education, Department Of Agricultural Research And Education (Dare) and other key government departments, Department of Atomic Energy is where the company has excelled.
Financial Performance Analysis
Yearly Trends: A review of yearly performance shows a mixed trajectory. From no activity in FY2018-19 and FY2019-20, they progressed to bidding on tenders in FY2020-21, FY2021-22, FY2022-23, FY2023-24, and FY2024-25. Notably, FY2022-23 saw the highest contract value at ₹9,10,70,541. In comparison, FY2023-24 had a contract value of ₹1,69,99,975 and FY2024-25 totaled ₹71,06,481.
Quarterly Patterns: Detailed quarter-wise visualizations (described here) indicate strong performance in Q1 and relatively weaker performance in Q3 across fiscal years. Agile Lifescience Technologies India's performance in Q3 needs improvement.